Bookmark1. 5-year distant disease-free survival was comparable between both groups. 2. 5-year...
Read More
Bookmark1. The median OS was 13.2 months with TTFields arm vs 9.9 months with standard arm, with...
Read More
Bookmark1. This phase 2 randomized clinical trial found that patients with metastatic colorectal...
Read More
Bookmark1. Disease-free survival at 24 months was 84% in the nivolumab group compared to 73% in...
Read More
Bookmark1. 37% of study patients had an objective response to treatment with atezolizumab. 2....
Read More
Bookmark1. The objective response rate was 29.8% (1% complete response, 66% partial response) with...
Read More
Bookmark1. Pooled overall survival and progression-free survival HR were found to be 0.95 and 0.88...
Read More
Bookmark1. This post-hoc analysis of the AMATERASU randomized clinical trial found that, for...
Read More
Bookmark1. In a cross-sectional study, adolescent survivors of childhood cancers were more...
Read More
Bookmark1. Complete response or remission was reported in 18% of patients who received a single...
Read More
Bookmark1. The risk of mortality from solid cancer, lagged by 10 years, is estimated to be...
Read More
Bookmark1. 5-year recurrence incidence was 2.5% at follow-up. 2. Overall survival at 5 years...
Read More
Bookmark1. Median progression-free survival was shown to be 27.7 months in the vorasidenib group...
Read More
Bookmark1. This phase 2, single-arm, multicenter trial found that in HER2-positive breast cancer...
Read More
Bookmark1. Median overall survival in the atezolizumab group was 10.3 months versus 9.2 months in...
Read More
Bookmark1. The pathological complete response rate for the experimental group was improved...
Read More
Bookmark1. At 24 months, more participants in the pembrolizumab group were alive without an event,...
Read More
Bookmark1. In this systematic review, seven core elements of a good death among cancer patients...
Read More
Bookmark1. Progression-free survival was significantly higher in the talazoparib plus enzalutamide...
Read More
Bookmark1. Initiating colorectal cancer screening at age 45 results in 12,188 fewer cases and...
Read More